Persistent Net LossesChronic losses erode equity and constrain the firm's ability to reinvest in R&D, capacity, or margin improvement. Over months this limits competitive responses, risks supplier/customer confidence, and may force asset sales or financing that dilute strategic options.
Material Revenue DeclineA near‑50% revenue decline reduces scale economics and increases per-unit fixed cost absorption, pressuring margins. Unless demand stabilizes, the revenue slump undermines recovery prospects and prolongs the period of negative profitability.
Weak, Volatile Cash GenerationIntermittent cash flows and a sharp drop in free cash flow weaken the firm's ability to fund operations and capex internally. This volatility raises the likelihood of reliance on external funding and constrains execution of medium-term recovery plans.